Compounds > n-2-hexyl-n-methylpropargylamine
Page last updated: 2024-09-03

n-2-hexyl-n-methylpropargylamine and levodopa

n-2-hexyl-n-methylpropargylamine has been researched along with levodopa in 1 studies

Compound Research Comparison

Studies
(n-2-hexyl-n-methylpropargylamine)		Trials
(n-2-hexyl-n-methylpropargylamine)		Recent Studies (post-2010)
(n-2-hexyl-n-methylpropargylamine)		Studies
(levodopa)		Trials
(levodopa)		Recent Studies (post-2010) (levodopa)
90017,7741,9004,946

Protein Interaction Comparison

ProteinTaxonomyn-2-hexyl-n-methylpropargylamine (IC50)levodopa (IC50)
integrase, partialHuman immunodeficiency virus 10.5939
lens epithelium-derived growth factor p75Homo sapiens (human)0.5939
Epidermal growth factor receptorHomo sapiens (human)2.88
Tyrosine-protein kinase LckHomo sapiens (human)3.729
Tyrosine-protein kinase FynHomo sapiens (human)2.146
Polyunsaturated fatty acid lipoxygenase ALOX15Oryctolagus cuniculus (rabbit)2.258

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lai, CT; Yu, PH1

Other Studies

1 other study(ies) available for n-2-hexyl-n-methylpropargylamine and levodopa

ArticleYear
R(-)-deprenyl potentiates dopamine-induced cytotoxicity toward catecholaminergic neuroblastoma SH-SY5Y cells.
    Toxicology and applied pharmacology, 1997, Volume: 142, Issue:1

    Topics: Antioxidants; Dopamine; Drug Synergism; Humans; Levodopa; Monoamine Oxidase Inhibitors; Neuroblastoma; Neuroprotective Agents; Oxidation-Reduction; Oxidative Stress; Pargyline; Propylamines; Reactive Oxygen Species; Selegiline; Tumor Cells, Cultured

1997